病毒释放
神经氨酸酶抑制剂
病毒学
奥司他韦
病毒
传输(电信)
大流行
爆发
甲型流感病毒
生物
病毒载量
医学
抗病毒药物
神经氨酸酶
2019年冠状病毒病(COVID-19)
内科学
传染病(医学专业)
疾病
工程类
电气工程
作者
Leo Lee,Jie Zhou,Rebecca Frise,Daniel H. Goldhill,Paulina Koszalka,Edin Mifsud,Kaoru Baba,Takahiro Noda,Yoshinori Ando,Kenji Sato,Aoe-Ishikawa Yuki,Takao Shishido,Takeki Uehara,Steffen Wildum,Elke Zwanziger,Neil Collinson,Klaus Kuhlbusch,Barry Clinch,Aeron C. Hurt,William Barclay
出处
期刊:PLOS Pathogens
[Public Library of Science]
日期:2020-04-15
卷期号:16 (4): e1008395-e1008395
被引量:34
标识
DOI:10.1371/journal.ppat.1008395
摘要
Influenza viruses cause seasonal outbreaks and pose a continuous pandemic threat. Although vaccines are available for influenza control, their efficacy varies each season and a vaccine for a novel pandemic virus manufactured using current technology will not be available fast enough to mitigate the effect of the first pandemic wave. Antivirals can be effective against many different influenza viruses but have not thus far been used extensively for outbreak control. Baloxavir, a recently licensed antiviral drug that targets the influenza virus endonuclease, has been shown to reduce virus shedding more effectively than oseltamivir, a widely used neuraminidase inhibitor drug. Thus it is possible that treatment with baloxavir might also interrupt onward virus transmission. To test this, we utilized the ferret model, which is the most commonly used animal model to study influenza virus transmission. We established a subcutaneous baloxavir administration method in ferrets which achieved similar pharmacokinetics to the approved human oral dose. Transmission studies were then conducted in two different locations with different experimental setups to compare the onward transmission of A(H1N1)pdm09 virus from infected ferrets treated with baloxavir, oseltamivir or placebo to naïve sentinel ferrets exposed either indirectly in adjacent cages or directly by co-housing. We found that baloxavir treatment reduced infectious viral shedding in the upper respiratory tract of ferrets compared to placebo, and reduced the frequency of transmission amongst sentinels in both experimental setups, even when treatment was delayed until 2 days post-infection. In contrast, oseltamivir treatment did not substantially affect viral shedding or transmission compared to placebo. We did not detect the emergence of baloxavir-resistant variants in treated animals or in untreated sentinels. Our results support the concept that antivirals which decrease viral shedding could also reduce influenza transmission in the community.
科研通智能强力驱动
Strongly Powered by AbleSci AI